SureScreen Diagnostics Competitors and Similar CompaniesClear all

SureScreen Diagnostics's competitors and similar companies include Summit Diagnostics, Saman Tajhiz Noor, Zhejiang Orient Gene Biotech and Autobio Diagnostics.

	SureScreen Diagnostics SureScreen Diagnostics is a company that provides rapid diagnostic equipment and services.	Summit Diagnostics Summit Diagnostics is a company that provides drug testing solutions.	Saman Tajhiz Noor Saman Tajhiz Noor is a company that develops laboratory equipment.	Zhejiang Orient Gene Biotech Zhejiang Orient Gene Biotech (浙江东方基因生物制品股份有限公司) is a company that manufactures and sells vitro diagnostic products,	Autobio Diagnostics Autobio Diagnostics (奧託生物診斷有限公司) is a manufacturer and supplier of medical diagnostics products.
Founding Date	Founding Date 1996	Founding Date 2007	Founding Date 1996	Founding Date 2005	Founding Date 1998
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare drug monitoring medical devices medical diagnostics	Tags Healthcare drug monitoring medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics
Locations	Locations Derby, GB HQ Cronulla, AU	Locations Salem, US HQ	Locations Tehran, IR HQ	Locations Huzhou, CN HQ	Locations Zheng Zhou Shi, CN HQ
Employees	Employees 53	Employees 18	Employees 32	Employees 2,231	Employees 5,773
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 945.9 m	Valuation ($) 3.6 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥910.7m (FY, 2025)	Revenue (est.) ¥4.1b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥560.9m (FY, 2025)	Cost of goods ¥1.5b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥366.6m (FY, 2025)	Gross profit ¥2.7b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income (¥597.4m) (FY, 2025)	Net income ¥1.1b (FY, 2025)